Overview

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and durability of effect of ALKS 9072 (also known as ALKS 9070) during long-term treatment of subjects with stable schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Alkermes, Inc.